8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Apr 19, 2017)

Filed April 19, 2017For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on April 19, 2017, to announce its first-quarter 2017 financial results. The report primarily furnishes a press release detailing these results, which are presented using both GAAP and non-GAAP financial measures. The company emphasizes that its non-GAAP figures, which exclude items like acquisition-related expenses, restructuring costs, and gains/losses from asset sales and foreign currency, are used internally by management to assess performance and provide investors with a clearer view of ongoing business operations. Investors should pay close attention to the non-GAAP adjustments as they can significantly impact reported earnings. While Abbott asserts these measures offer valuable insights into underlying business performance, they should be considered alongside, not as a replacement for, GAAP-compliant financial data. The filing indicates that the detailed financial performance is available in the press release furnished as an exhibit.

Key Highlights

  • 1Abbott Laboratories announced its first-quarter 2017 financial results on April 19, 2017.
  • 2The 8-K filing incorporates a press release (Exhibit 99.1) containing the detailed earnings announcement.
  • 3The company utilized both GAAP and non-GAAP financial measures to report results.
  • 4Non-GAAP measures exclude specified items such as acquisition costs, restructuring, asset sale gains/losses, and currency impacts.
  • 5Abbott's management uses non-GAAP measures to evaluate ongoing business performance internally.
  • 6Investors are advised to consider non-GAAP measures in addition to GAAP measures.
  • 7Brian B. Yoor, Executive Vice President, Finance and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce Abbott Laboratories' financial results for the first quarter of 2017, as detailed in an accompanying press release.

Non-GAAP financial measures are financial metrics that exclude certain items that may not be indicative of ongoing operational performance. Abbott uses them to provide investors with a clearer view of the company's underlying business performance by adjusting for unusual or unpredictable factors such as acquisition-related costs, restructuring charges, and gains/losses from asset sales or foreign currency fluctuations.

GAAP (Generally Accepted Accounting Principles) are standard accounting rules. Non-GAAP measures are adjustments to GAAP figures. While Abbott's management believes non-GAAP measures offer valuable insights into performance, investors should consider them alongside, and not as a substitute for, the financial results prepared in accordance with GAAP.

The detailed financial results are provided in the press release dated April 19, 2017, which is furnished as Exhibit 99.1 to this 8-K filing and incorporated by reference.